1. Clinical Overview
A fixed-dose combination (FDC) of an anti-filarial agent (Diethylcarbamazine) and a second-generation antihistamine (Cetirizine). Primarily used for the treatment and prophylaxis of lymphatic filariasis (caused by Wuchereria bancrofti and Brugia malayi) while managing the associated allergic and inflammatory symptoms (Mazzotti reaction) that occur due to the death of microfilariae. Cetirizine helps mitigate the pruritus, rash, and angioedema that can accompany DEC therapy.
| Onset | Duration | Bioavailability |
|---|---|---|
| Diethylcarbamazine: Anti-filarial action begins within hours. Cetirizine: 20-60 minutes after oral administration. | Diethylcarbamazine: Plasma half-life is 8-12 hours, but dosing is typically once daily for mass drug administration (MDA). Cetirizine: 24 hours, allowing once-daily dosing. | Diethylcarbamazine: Approximately 75-85%. Cetirizine: Well absorbed (>70%). |
2. Mechanism of Action
Diethylcarbamazine (DEC) immobilizes microfilariae by altering their surface membranes, making them susceptible to host phagocytosis. It also damages adult worms. Its exact molecular target is unclear but may involve arachidonic acid metabolism. Cetirizine is a potent and selective antagonist of peripheral H1 receptors, inhibiting the histamine-mediated allergic response triggered by dying microfilariae.
3. Indications & Uses
- Treatment of Bancroftian and Brugian lymphatic filariasis
- Mass Drug Administration (MDA) for prophylaxis in endemic areas of India
4. Dosage & Administration
Adult Dosage: One tablet (Diethylcarbamazine 300mg + Cetirizine 10mg) orally, once daily. For MDA: A single dose annually. For treatment: 6mg/kg/day in divided doses for 12 days, often given as this FDC once daily.
Administration: Take after food to minimize gastric upset. Tablet can be taken with a full glass of water. For MDA programs, administration is directly observed. Do not crush or chew unless advised.
5. Side Effects
Common side effects may include:
- Drowsiness/sedation (Cetirizine)
- Headache
- Dizziness
- Dry mouth
- Nausea, vomiting, anorexia (DEC)
- Fatigue
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| CNS Depressants (Alcohol, Benzodiazepines, Opioids) | Additive sedative effect with Cetirizine | Major |
| Theophylline | May decrease DEC's clearance, increasing risk of DEC toxicity | Moderate |
| Other Antihistamines (e.g., Hydroxyzine, Diphenhydramine) | Additive anticholinergic and sedative effects | Moderate |
| Drugs prolonging QT interval (e.g., Erythromycin, antipsychotics) | Theoretical risk of additive QT prolongation with Cetirizine (low risk at 10mg) | Moderate |
| Mebendazole/Albendazole | Often co-administered in MDA for synergistic anti-helminthic effect. No major pharmacokinetic interaction known. | Minor |
7. Patient Counselling
- DO take the tablet after food.
- DO complete the full course as prescribed, even if symptoms improve.
- DO inform your doctor if you are pregnant, planning pregnancy, or breastfeeding.
- DO inform your doctor about all other medicines you are taking.
- DONT consume alcohol while on this medication.
- DONT drive or operate heavy machinery if you feel drowsy or dizzy.
- DONT take this medicine if you have been diagnosed with 'river blindness' (onchocerciasis).
8. Toxicology & Storage
Overdose: DEC Overdose: Nausea, vomiting, dizziness, headache, hypotension, confusion, seizures. Cetirizine Overdose: Drowsiness, agitation, restlessness, tachycardia, urinary retention, in severe cases QT prolongation and arrhythmias.
Storage: Store below 30°C in a cool, dry place. Protect from light and moisture. Keep out of reach of children.